Many people stop taking GLP-1 drugs like Ozempic within a year, but doing so often leads to weight regain. Here's what to know before stopping.

The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide ...

The researchers first tested their hypothesis by delivering ODN directly to the hindbrain of rats. Once treated, the rats ...

New research reveals weight-loss drugs help during treatment but weight returns rapidly after stopping. Experts urge ...

Older adults and women using Wegovy for obesity management may be more likely to lose lean mass, although increasing protein intake may help protect against lean mass loss, according to a speaker.

Common medicines, including diabetes, cancer, and antiviral drugs, may offer new hope in slowing dementia. UK researchers, including a team from the University of Cambridge, have uncovered strong ...

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...

Significant periods of weight regain were observed at eight, 12, and 20 weeks after stopping the anti-obesity medications. The analysis revealed that the weight rebound typically continued for an ...

According to a recent study, nearly three in four Americans are overweight. Worse, this report predicts that for decades to ...

Patients put on weight loss drugs like Ozempic and Wegovy may start regaining weight within weeks of discontinuing them, a ...